Concepedia

Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG)

Emmanouil Saloustros, Nikolaos Malamos, Ioannis Boukovinas, Stylianos Kakolyris, C. Kouroussis, Athanasios Athanasiadis, Nikolaos Ziras, Nikolaos Kentepozidis, P. Makrantonakis, Aristidis Polyzos,

Breast Cancer Research and Treatment · 2014 · 18 citations · 18 references

DOI

Concepts

References

18

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

Marc L. Citron, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2003 · 1.6K citations

, , +15

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

I. Craig Henderson, Donald A. Berry, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 1.3K citations

, , +17

Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

Joseph A. Sparano, Molin Wang, Silvana Martino et al. · New England Journal of Medicine · 2008 · 1K citations · Full text

, , +13

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

, , +13

Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

Eleftherios P. Mamounas, John Bryant, Barry C. Lembersky et al. · Journal of Clinical Oncology · 2005 · 714 citations

, , +17